Skip to main content
OpenTrials
Completed

NCT Number: NCT04802850

Investigation of Immediate, Short and Long Term Effects of Mulligan Mobilization With Movement Techniques in Nonspesific Chronic Low Back Pain

Introduction: Although the effectiveness of many mobilization methods in chronic low back pain (CLBP) was shown, these effects were not monitored in the long term. The aim of this study was to identify the immediate, short and long-term effects of mulligan mobilization with movement (MWM) in terms of pain, range of motion (ROM), flexibility, endurance, functionality and disabilities in patients with CLBP. Methods: The study was designed in randomized-placebo controlled with 36 people randomly distributed into 2 groups. Sustained natural apophyseal glide (SNAG) was applied to the lumbar region, straight leg raise (SLR) with traction to the hip, and internal rotational mobilization techniques and home exercise program were applied in Group 1 (n=19); and the same techniques were applied as sham mobilization in Group 2 (n=17). The evaluations were made as post-intervention for immediate effect, and were also made at the 5th week, 3rd month, and 6th months for short and long-term effect. Evaluation was also made for pain in 12th month.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Low Back Pain

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having 3 months' continuous or intermittent LBP symptoms, without leg pain above the knee
  • Pain at VAS > 3/10,
  • Back pain increased by active lumbar flexion movement

Exclusion criteria

  • Confirmed nerve root compression
  • Neurological symptoms
  • Lumbar spine stenosis
  • Back surgery history
  • Chronic pain syndrome
  • LBP from fracture
  • Infection
  • Visceral disease
  • Pregnancy
  • Major clinical depression
  • Cauda equina syndrome
  • Significant osteoporosis.

Treatment and study plan

Mulligan Mobilization with Movement

Other

Primary outcomes

  1. Flexibility

    Time frame: immediate(post intervention)-5 weeeks(after 5 week treatment)-3 months(after 3 months)-6 months(after 6 months)

    Change of lumbar flexibility with sit and reach objective test( cm)

  2. Endurance

    Time frame: immediate(post intervention)-5 weeeks(after 5 week treatment)-3 months(after 3 months)-6 months(after 6 months)

    Change of endurance of lumbar extensors with Sorensen endurance test(sn)

  3. Functionality with patient specific function scale

    Time frame: immediate(post intervention)-5 weeeks(after 5 week treatment)-3 months(after 3 months)-6 months(after 6 months)

    Change of function

  4. Disabilities with Oswestry disability index(scale)

    Time frame: immediate(post intervention)-5 weeeks(after 5 week treatment)-3 months(after 3 months)-6 months(after 6 months)

    Change of disabilities

Secondary outcomes

  1. range of motion with goniometer

    Time frame: immediate(post intervention)-5 weeeks(after 5 week treatment)-3 months(after 3 months)-6 months(after 6 months)-12 months

    change of range of motion

Sponsors and collaborators

Lead sponsor

Suleyman Demirel University

Other

Registry information

Official study title

Investigation of Immediate, Short and Long Term Effects of Mulligan Mobilization With Movement Techniques in Nonspesific Chronic Low Back Pain: a Randomized Placebo-controlled Trial

Important dates

Study start
2013
Primary completion
2014
Study completion
2015
First posted
Mar 17, 2021
Registry last updated
Mar 17, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.